The expected outcome of a CLIN2 award is completion of a single interventional clinical trial. CIRM anticipates funding between 9-16 CLIN2 awards in fiscal year 2025-2026, contingent on the number of ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

The statewide network is designed to overcome manufacturing bottlenecks that have delayed or stalled development and approval of regenerative medicines. “These awards are a critical first step in ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

Sur de San Francisco, CA, 28 de junio de 2024 – El Instituto de Medicina Regenerativa de California (CIRM), una de las instituciones más grandes del mundo dedicada a la medicina regenerativa, otorgó ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Patients afflicted with recurrent fast and irregular heart beating (a.k.a. ventricular tachycardia). CSHHI-2003 (CDC exosomes) are lipid vesicles filled with bioactive materials that have ...

The CIRM iPSC Repository is a collection of induced pluripotent stem cell (iPSC) lines produced from tissue samples obtained from thousands of individuals by researchers in California through funding ...

Foundation – Discovery Stage Research Projects Xiaojie Qiu Mapping and modeling endothelial cell fate decisions for pulmonary arterial hypertension $1,540,798 Foundation – Discovery Stage Research ...